Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel
Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health…
Baylor Genetics to Highlight Genetic Testing Use Cases and Advancements in Rare Disease at The National Society of Genetic Counselors 44th Annual Conference
HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic…
H.H.C. Group Achieves ISO/IEC 27001:2022 Certification, Strengthening Commitment to Data Security and Client Trust
ROCKVILLE, Md., Nov. 04, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader…
Ride for a Cause, Rally for a Cure: Manipal Hospital Yeshwanthpur Leads the Charge Against Breast Cancer
BENGALURU, India, Nov. 4, 2025 /PRNewswire/ -- The streets of Bengaluru turned…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
Rendever Receives Nearly $4.5 Million in NIH Funding to Overcome Social Isolation for Older Adults while Supporting Caregivers
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Rendever, the company leading the…
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
Two oral and seven poster presentations further support the CARVYKTI® research in…
Viraj Profiles Organises Eye Check-Up Camp for School Children in Boisar
MUMBAI, India, Nov. 3, 2025 /PRNewswire/ -- Leading stainless steel manufacturer Viraj…
Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement
COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…